Approvals/TGA/STREPFEN ANTI-INFLAMMATORY flurbiprofen 8.75 mg orange flavour lozenge blister pack (reformulation)

Approved

STANDARD

STREPFEN ANTI-INFLAMMATORY flurbiprofen 8.75 mg orange flavour lozenge blister pack (reformulation)

Reckitt Benckiser Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 609dc3859b8c151f
Product Name: STREPFEN ANTI-INFLAMMATORY flurbiprofen 8.75 mg orange flavour lozenge blister pack (reformulation)
Artg Id: 157020
Artg Name: STREPFEN ANTI-INFLAMMATORY flurbiprofen 8.75 mg orange flavour lozenge blister pack (reformulation)
Sponsor: Reckitt Benckiser Pty Ltd
Company Detail Path: /organization/reckitt-benckiser-australia-pty-ltd
Artg Date: 2008-11-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 28, 2025

Approval ID

609dc3859b8c151f

Type

Standard